|
SPAG5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.347700E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.453600E-02 |
| Normal-vs-Stage2 |
1.140750E-03 |
| Normal-vs-Stage3 |
2.707900E-02 |
| Normal-vs-Stage4 |
8.670300E-02 |
| Stage1-vs-Stage2 |
4.116300E-02 |
| Stage1-vs-Stage3 |
5.454400E-01 |
| Stage1-vs-Stage4 |
9.853200E-01 |
| Stage2-vs-Stage3 |
1.080040E-01 |
| Stage2-vs-Stage4 |
4.678200E-02 |
| Stage3-vs-Stage4 |
5.502800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.467750E-02 |
| Normal-vs-AfricanAmerican |
1.587900E-02 |
| Normal-vs-Asian |
4.390800E-01 |
| Caucasian-vs-AfricanAmerican |
6.084000E-01 |
| Caucasian-vs-Asian |
3.714400E-01 |
| AfricanAmerican-vs-Asian |
3.613400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.195000E-04 |
| Normal-vs-Female |
8.784400E-01 |
| Male-vs-Female |
8.43900000000453E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.440200E-03 |
| Normal-vs-Age(41-60Yrs) |
7.723800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.146580E-01 |
| Normal-vs-Age(81-100Yrs) |
8.738600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.291200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.737900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.175800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.396600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.741600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.151400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.386600E-01 |
| Normal-vs-Grade 2 |
1.506200E-01 |
| Normal-vs-Grade 3 |
7.922000E-03 |
| Normal-vs-Grade 4 |
2.216300E-02 |
| Grade 1-vs-Grade 2 |
2.669600E-01 |
| Grade 1-vs-Grade 3 |
4.663500E-02 |
| Grade 1-vs-Grade 4 |
6.941500E-02 |
| Grade 2-vs-Grade 3 |
2.241000E-01 |
| Grade 2-vs-Grade 4 |
3.803400E-01 |
| Grade 3-vs-Grade 4 |
7.930000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.609400E-01 |
| Normal-vs-ccB subtype |
6.455100E-03 |
| ccA subtype-vs-ccB subtype |
8.604000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.794420E-01 |
| Normal-vs-N1 |
7.197800E-01 |
| N0-vs-N1 |
5.930400E-01 |
|
|
